English Deutsch 中文
  • Innovative Solutions
  • Expert Support and Knowledge
  • Reliable Cooperation
Menu Deutsch 中文

Conba Pharma Forms JV with American Kite Pharma to Develop Cancer Treatment

Jun. 13, 2011

On June 14, 2011 Zhejiang Conba Pharma announced its plans to form a JV with Kite Pharma, a development stage oncology startup, which will be headquartered in Hangzhou and initially funded with a $1.2 million investment from Conba.
Kite is developing cancer immunotherapies using alpha fetoproteins (AFPs), which now is in Phase I under FDA regulations.